ANZSNM 2017 Pre-Conference Symposium Program – 12.04.17 FRIDAY 21 APRIL 2017 07:30: Registration 08:00: Transfer to the MONA (Museum of Old and New Art) 08:30: Arrival Tea and Coffee 09:00: Welcome and Opening 09:10: Cardiology Hypotheticals – Moderator A/Prof Nathan Better Issues confronting Imaging in Nuclear Cardiology in this decade Panellists: Dr John Younger, Dr Samuel Wright and Dr Subodh Joshi 10:30: Morning Tea 10:50: Prostate Imaging –Moderator A/Prof Paul Roach Panellists: Dr Hossein Jadvar, A/Prof Paul Thomas and Dr Geoffrey Schembri 12:00: Discussion and Working Lunch 12:45: Time to explore MONA 14:30: Transfers back to The Hotel Grand Chancellor ANZSNM 2017 ASM Program – 30.03.17 FRIDAY 21 APRIL 2017 15:00: Registration 16:00: Official Opening - Concert Hall 16:15: CT, MRI and Echo in Ischaemia Imaging – Dr John Younger Consultant Cardiologist, Royal Brisbane and Women’s Hospital, St Andrews War Memorial Hospital; Senior Lecturer, University of Queensland 17:00: PET in Radiation Planning - Evidence Gathering - Dr Sally Barrington, Professor of PET Imaging, Kings College London and the Guy’s and St Thomas’ PET Imaging Centre UK, UK 17:45: Welcome Reception - Federation Ballroom (Sponsored by GE Healthcare) 19:30: AANMS Fellows' Dinner - Henry Jones Art Hotel SATURDAY 22 APRIL 2017 07:00 - 08:15: PETTECH Solutions & ANSTO Breakfast Session - Grand Ballroom 1 07:00: Registration Plenary - Concert Hall (Sponsored by Siemens Healthineers) 08:30: PSMA PET the new gold standard or is more evidence needed? - Associate Professor Michael Hofman, Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne & University of Melbourne, Melbourne 09:15: PET in Lymphoma - impact on patient outcomes - Dr Sally Barrington, Professor of PET Imaging, Kings College London; Guy’s and St Thomas’ PET Imaging Centre UK, UK 10:00: Morning tea/Poster viewing - Federation Ballroom 10:30 - 13:00: Concurrent sessions 1A - 1D 1A Technologists' Symposium 1 - 1B AANMS Symposium 1 - 1C Physics Symposium 1 1D Radiopharmacy Symposium 1 (Sponsored by GMS) AANMS Registrar Award Grand Ballroom 3 - Shimadzu Award* Grand Ballroom 2 Harbour View 1 Radpharm Award Grand Ballroom 1 10:30: Recognizing and Resolving 104 O7 10:30: Correlation of metabolic 118 O13 10:30: 3D Printing of Solid 10:30: Efforts on Production / Artifact in Myocardial Perfusion parameters on 18F-FDG PET Radioactive Phantoms Propagation of Imaging Sara Johnson SNMMI-TS with pathological response and Shaun Patford, Royal Brisbane Radiopharmaceuticals and overall survival in patients with Women's Hospital Isotopes Pancoast tumours treated with Dr Meera Venkatesh, trimodality therapy International Atomic Energy Samuel McArthur, Austin Health Agency, Austria 229 O1 11:00: Cerebral Perfusion 122 O8 10:45: Pre-treatment staging 132 O14 10:45: Development of an 194 O19 11:00: Development and Scintigraphy and Its Use in FDG PET/CT assessment of internationally traceable Process Validation of [18F]GE- Surgical Evaluation Mantle Cell Lymphoma: A standard for Ge/Ga-68 216 on FASTlabTM Synthesizer; Alicia Corlett, Royal Melbourne comparison of visual assessment Freda van Wyngaardt, ANSTO A Radiotracer for Imaging Tau Hospital versus assessment by Pathology quantitative FDG parameters. Chun-Hui (Brenda) Tai, Royal Methodology and preliminary Brisbane and Women’s Hospital data Shane Lee, Barwon Health 230 O2 11:10: The utility of PET-MRI in 169 O9 11:00: PET-SUV max and 137 O15 11:00: Comparing 2D and 3D 110 O20* 11:12: Aqueous Labelling the treatment planning and upstaging of Lung cancer kidney absorbed dose Method for [18F]Aluminium- management of meningiomas Shipra Verma , Royal Adelaide measures in patients receiving Fluoride NOTA-Ubiquicidin(29- Judy Duong , The Princess Hospital 177Lu-DOTATATE therapy for 41), an Infection Imaging Probe Alexandria Hospital neuroendocrine tumours Joseph Ioppolo, Sir Charles Dale Bailey, The University of Gairdner Hospital Sydney 231 O3 11:20: Renogram reveals an 190 O10 11:15: Retrospective Audit of 153 O16 11:15: Influence of X ray 145 O21* 11:24: Reducing the time of QC unexpected finding: a case study GA68 PSMA PET/CT, Bone computed tomography (CT) on ECD without compromising Danielle Nuske, Radiology SA Scintigraphy and Diagnostic CT exposure and reconstruction quality In The Staging Of Prostate parameters on positron Adam Livori, Austin Health Cancer Shankar emission tomography (PET) Vamadevan, Nepean Hospital quantitation - a statistical voxel based analysis Ivan Ho Shon, Prince of Wales Hospital 232 O4 11:30: There is nothing like a nice 106 O11 11:30: The Goldilocks 235 O17 11:30: Characterisation of 187 O22 11:36: Imaging of TG2 activity in warm bath conundrum for I-131: What dose Noise and Sensitivity Variations breast cancer using Sharyn Bray, Midcentral Health is just right? in Multiple Bed Position radiolabelled Hitomi peptides Tow Chan Yeow, St George Acquisitions for 18F-FDG brain Uwe Ackermann, Austin Health Hospital PET Tom Hennessy, Prince of Wales Hospital 233 O5 11:40: A Multimodality Approach 135 O12 11:45: The relationship between 218 O18 11:45: The challenge of very 179 O23 11:48: High-yield fully - A Difficult Case chest pain or ECG changes movable removable automated production of Rebecca Ross, PRP Imaging during stress testing and contamination in radioiodine [18F]Fluorocholine at high Bathurst ischaemia on myocardial therapies activity on the AllinOne perfusion imaging Darin O'Keeffe, Christchurch Synthesizer Sidney Levy, Melbourne Health Hospital Thomas Vergote, Trasis SA 114 O6 11:50: Nuclear Medicine: Seen but not Heard Amy Evans, Sir Charles Gairdner Hospital 12:00: Technologists' AGM 12:00: AANMS AGM 12:00: Physics AGM 12:00: Radiopharmacy AGM 13:00: Lunch/Poster viewing - Federation Ballroom Plenary - Concert Hall 14:00: Lowenthal Lecture - Professor Vijay Kumar AM, Clinical Professor, Sydney Medical School, Sydney University; Principal Scientist, Department of Nuclear Medicine & PET Westmead Hospital & The Children's Hospital at Westmead 14:45 - 15:30: Concurrent sessions 2A - 2D 2A Technologists' Symposium 2 - 2B AANMS Symposium 2 2C Physics Symposium 2 2D Radiopharmacy Symposium 2 (Sponsored by GMS) Grand Ballroom 2 Grand Ballroom 3 Harbour View 1 Mallinckrodt Award Grand Ballroom 1 140 O24 14:45: Prescribed Paediatric 163 O28 14:45: A Phase 1 and 154 O31 14:45: Comparison of cell 14:45: US GMP Production Radiopharmaceutical Dose Versus Biodistribution Study of ABT- survival after exposure to Regulations for both Clinical and Administered Dose - How Close 806i, An Indium-111 megavoltage external beam Research Can We Get It? Radiolabeled Conjugate of the and Ytrrium-90 radiation Sally Schwarz, Washington Victoria Sigalas, Women's and Tumor-Specific Anti-EGFR Nicholas Forwood, Royal North University School of Medicine, Children's Hospital Antibody ABT-806 Shore Hospital USA Andrew Scott, Austin Health 111 O25 14:57: The effect of ingesting full 202 O29 15:00: Sandostatin LAR therapy 103 O32 15:00: Australian National cream milk and water on infra differentially alters 68Ga- Radiation Dose Register cardiac activity in patients taking DOTATATE uptake in normal (ANRDR) Review proton pump inhibitors prior to tissues and primary tumours Cameron Lawrence, Australian 99mTc Sestamibi Myocardial compared to metastatic lesions Radiation Protection and Perfusion Imaging Sze Ting Lee, Austin Health Nuclear Safety Agency Travis Cauchi, Eastern Health 159 O26 15:09: Education is everyone's 201 O30 15:15: Implementation of a 200 O33 15:15: Dissemination of 144 O34 15:15: Development and business: A study to identify the clinical reporting quality standards for F-18 FDG evaluation of a new highly importance of incorporating assurance program in a hospital- Bonnie Howe, ANSTO specific TREM1-specific PET education principles within the based PET service tracer for imaging maladaptive Nuclear Medicine profession Salvatore Berlangieri, Austin inflammation Suzanne McGavin, Royal Brisbane Health Michelle James, Stanford and Women's Hospital University 115 O27 15:21: Using a formula based on BMI and BSL for administration of Actrapid for FDG-PET scans where the patient's BSL is elevated on arrival Lisa MacFarlane, Peter MacCallum Cancer Centre 15:30: Afternoon tea/Poster viewing - Federation Ballroom 16:00 - 17:00: Concurrent sessions 3A – 3C 3A Technologists' Symposium 3 3B AANMS Symposium 3 3C Physics Symposium 3 (Sponsored by GMS) Grand Ballroom 2 Grand Ballroom 3 Grand Ballroom 1 134 O35 16:00: Casting the NET: The 165 039 16:00: Comparison of PSMA 186 O41 16:00: Creating Local Reference . formation of a NET Health PET/CT, PSMA PET/MR and Levels of Administered Activity Professionals Network multiparametric MR in the Using Text Analysis of Physician Kate Wakelin, Unicorn detection of primary prostate Reports Foundation cancer Kevin Hickson, SA Medical Paul Thomas, Royal Brisbane and Imaging, The Queen Elizabeth Women's Hospital Hospital 125 O36 16:15: A study to compare and 142 O40 16:15: 177Lu-DOTA-Octreotate 167 O42 16:15: Diagnostic reference levels contrast the regulation Peptide Receptor Radionuclide for FDG PET/CT studies in New processes for Medical Radiation Therapy (PRRT) in patients with Zealand Practitioners in Australia and Functional and Metastatic Essam Al Khybari, The University New Zealand Phaeochromocytoma (PCC) or of Sydney Travis Pearson, Medical Paraganglioma (PGL) Radiation Practice Board Grace Kong, Peter MacCallum Australia Cancer Centre 176 O37 16:30: Comparative Analysis of 16:30: ARTnet 16:30: Improving